Cyclin G2 dysregulation in human oral cancer

Cancer Research

Volumn 64, Issue 24, 2004, Pages 8980-8986

  Kim, Yong ^a   Shintani, Satoru ^b   Kohno, Yohko ^c   Zhang, Rong ^a   Wong, David T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN G2; CYCLINE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LASER CAPTURE MICRODISSECTION; MOUTH CANCER; PRIORITY JOURNAL; RNA INTERFERENCE; WESTERN BLOTTING;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL GROWTH PROCESSES; CYCLINS; DOWN-REGULATION; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MICE; MOUTH NEOPLASMS; NIH 3T3 CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; TRANSFECTION; TUMOR STEM CELLS;

EID: 10844253962     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1926     Document Type: Article

References (23)

1. Califano A, Stolovitzky G, Tu Y. Analysis of gene expression microarrays for phenotype classification. Proc Int Conf Intell Syst Mol Biol 2000;8:75-85.
2. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996;56:2488-92.
3. Mao L. Leukoplakia: molecular understanding of pre-malignant lesions and implications for clinical management. Mol Med 1997;442-8.
4. Tsuji T, Duh FM, Latif F, et al. Cloning, mapping, expression, function, and mutation analyses of the human ortholog of the hamster putative tumor suppressor gene doc-1. J Biol Chem 1998;273:6704-9.
5. Papadimitrakopoulou V, Izzo J, Lippman SM, et al. Frequent inactivation of p16INK4a in oral premalignant lesions. Oncogene 1997;14:1799-803.
6. Alevizos I, Mahadevappa M, Zhang X, et al. Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene 2001;20:6196-204.
7. Sherr CJ. Mammalian G1 cyclins. Cell 1993;73:1059-65.
8. Okamoto K, Beach D. Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J 1994;13:4816-22.
9. Jensen MR, Audolfsson T, Keck CL, Zimonjic DB, Thorgeirsson SS. Gene structure and chromosomal localization of mouse cyclin G2 (Ccng2). Gene (Amst) 1999;230:171-80.
10. Bates S, Rowan S, Vousden KH. Characterisation of human cyclin G1 and G2: DNA damage inducible genes. Oncogene 1996;13:1103-9.
11. Home MC, Donaldson KL, Goolsby GL, et al. Cyclin G2 is up-regulated during growth inhibition and B cell antigen receptor-mediated cell cycle arrest. J Biol Chem 1997;272:12650-61.
12. Bennin DA, Arachchige Don AS, Brake T, et al. Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B' subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest. J Biol Chem 2002;15:15.
13. Ito Y, Yoshida H, Uruno T, et al. Decreased expression of cyclin G2 is significantly linked to the malignant transformation of papillary carcinoma of the thyroid. Anticancer Res 2003;23:2335-8.
14. Frasor J, Danes JM, Komm B, et al. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 2003;144:4562-74.
15. Martinez-Gac L, Marques M, Garcia Z, Campanero MR, Carrera AC. Control of cyclin G2 mRNA expression by forkhead transcription factors: novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead. Mol Cell Biol 2004;24:2181-9.
16. Kim Y, Tsuji T, Elovic A, et al. Murine doc-1 cDNA cloning, sequencing and expression in normal adult tissues. Int J Oral Biol 2002;26:87-92.
17. Home MC, Goolsby GL, Donaldson KL, et al. Cyclin G1 and cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expression. J Biol Chem 1996;271:6050-61.
18. Ohyama H, Zhang X, Kohno Y, et al. Laser capture microdissection- generated target sample for high-density oligonucleotide array hybridization. Biotechniques 2000;29:530-6.
19. Bennin DA, Arachchige Don AS, Brake T, et al. Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B' subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest. J Biol Chem 2002;277:27449-67.
20. Tian YL, Liu FR, Liu J, et al. Ectopic expression of cyclin G2 inhibits cell proliferation in HeLa cancer cell line [in Chinese]. Ai Zheng 2002;21:577-81.
21. Dickson MA, Hahn WC, Ino Y, et al. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 2000;20:1436-47.
22. Todd R, Hinds PH, Munger K. et al. Cell cycle dysregulation in oral cancer. Crit Rev Oral Biol 2002;13:51-61.
23. Polverini PJ, Nor JE. Apoptosis and predisposition to oral cancer. Crit Rev Oral Biol Med 1999;10:139-52.